Research programme: cancer vaccines - Pan-Provincial Vaccine Enterprise
Latest Information Update: 30 Aug 2011
At a glance
- Originator Pan-Provincial Vaccine Enterprise
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 29 Aug 2011 Early research in Cancer in Canada (unspecified route)